Adium Mexico provides access to effective and innovative treatments for patients in Mexico, aiming to improve their quality of life. Adium Mexico is considered a partner of choice for innovative companies looking to expand their products across Latin America.

Adium

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication and infusion therapy delivery systems, medication compounding workflow systems, automated medication dispensing and supply management systems, and medication inventory optimization and tracking systems; syringes, pen needles, and other products for diabetes; and prefillable drug delivery systems. Its BD Life Sciences segment provides specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The company's BD Interventional segment offers hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention, surgical and laparoscopic instrumentation products; peripheral intervention products; and urology and critical care products. The company was founded in 1897 and is based in Franklin Lakes, New Jersey.

Maxwell Becton

Fairleigh Dickinson

Becton, Dickinson and Company

Cardinal Health, Inc. operates as an integrated healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. The company operates in two segments, Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The segment also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; operates nuclear pharmacies and radiopharmaceutical manufacturing facilities; repackages generic pharmaceuticals and over-the-counter healthcare products; and offers medication therapy management and patient outcomes services to hospitals, other healthcare providers, and payers, as well as provides pharmacy management services to hospitals. The Medical segment manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compressions; incontinences; nutritional delivery products; wound care products; single-use surgical drapes, gowns, and apparels; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. The segment also distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile, and non-sterile procedure kits. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.

Robert Walter

Cardinal Health, Inc.

Heritage Medical Associates is a physician-led medical practice providing comprehensive healthcare services to patients in the Nashville area.

Metric
Company Name	Adium	Becton, Dickinson and Company	Cardinal Health, Inc.	Heritage Medical Associates
Symbol		BDX	CAH
MSH ID	MX:COM:ADIUM	COM:BD	COM:CARDINALHEALTH	COM:HERITAGEMEDICAL
Market	PRIVATE	STOCKS	STOCKS	PRIVATE
Sector	Healthcare & Health Services	Healthcare	Healthcare	Healthcare & Health Services
Industry	Pharmaceutical distribution and market access	Medical - Instruments & Supplies	Medical - Distribution	Healthcare
Country	MX	US	US	US
Stage
Employee Count		70K	47.04K
Website	adium.com.mx	bd.com	cardinalhealth.com	heritagemedical.com
LinkedIn		bd1		heritage-medical-associates-p.c.
Founders

Metric
Market Cap	64.70B	23.28B
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue	20.18B	226.83B
Revenue (LTM)
Revenue (NTM)
Gross Profit	20.18B	7.41B
EBITDA	2.42B	1.24B
Operating Income	2.42B	1.24B
Net Income	1.73B	852M
EPS	5.96	3.48
Diluted EPS	5.93	3.45
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin	0.55	0.03
Operating Profit Margin	0.12	0.01
EBITDA Margin	0.12	0.01
Net Profit Margin	0.07	0.00
Return on Equity	0.06	-0.17
Return on Assets	0.03	0.02
Return on Capital Employed	0.05	0.17

MX:COM:ADIUM

Adium

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio	54.49	39.78
P/B Ratio	2.70	-7.37
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio	3.63	0.13
EV Multiple	15.21	9.86

Metric
Days Sales Outstanding	42.45	19.91
Days Payables Outstanding		59.85
Days Inventory Outstanding	105.52	32.24
Operating Cycle	151.20	52.14
Cash Conversion Cycle	47.37	-6.21
Asset Turnover	0.37	5.03

Metric
Operating Cash Flow	3.84B	3.76B
Free Cash Flow	3.12B	3.25B
Cash Flow to Debt	0.21	0.84
Operating Cash Flow/Sales	0.20	0.02
Free Cash Flow Yield	0.04	0.13

Metric
Cash & Equivalents	1.86B	5.13B
Accounts Receivable		-996M
Inventory	3.84B	14.96B
Goodwill	26.46B
Debt to Capitalization	0.43	3.71
Debt to Assets	0.33	0.10
Current Ratio	1.08	0.98
Quick Ratio	1.36	0.56

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue	0.01	0.00
R&D to Revenue	0.06
SG&A to Revenue